A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

Annals of the Rheumatic Diseases

Volumn 70, Issue 4, 2011, Pages 638-641

  Bossini Castillo, Lara ^a   Broen, Jasper C A ^b   Simeon, Carmen P ^c   Beretta, Lorenzo ^d   Vonk, Madelon C ^b   Ortego Centeno, Norberto ^e   Espinosa, Gerard ^f   Carreira, Patricia ^g   Camps, María Teresa ^h   Navarrete, Nuria ⁱ   González Escribano, María F ^j   Vicente Rabaneda, Esther ^k   Rodríguez, Luis ^l   Tolosa, Carlos ^m   Román Ivorra, José A ⁿ   Gómez Gracia, Inmaculada ^o   García Hernández, Francisco J ^j   Castellví, Iván ^p   Gallego, María ^q   Fernández Nebro, Antonio ^h   García Portales, Rosa ^r   Egurbide, María Victoria ^s   Fonollosa, Vicente ^c   De La Peña, Paloma García ^t   Pros, Ana ^u   González Gay, Miguel A ^v   Hesselstrand, Roger ^w   Riemekasten, Gabriela ^x   Witte, Torsten ^y   Coenen, Marieke J H ^b   Koeleman, Bobby P ^z   Houssiau, Frederic ^aa   Smith, Vanessa ^ab   De Keyser, Filip ^ab   Westhovens, Rene ^ac   De Langhe, Ellen ^ac   Voskuyl, Alexandre E ^ad   Schuerwegh, Annemie J ^ae   Chee, Meng May ^af   Madhok, Rajan ^af   Shiels, Paul ^af   Fonseca, Carmen ^ag   Denton, Christopher ^ag   Claes, Kathleen ^ab   Padykov, Leonid ^ah   Nordin, Annika ^ah   Palm, Øyvind ^ai   Lie, Benedicte A ^ai   Airó, Paolo ^aj   Scorza, Raffaella ^d   Van Laar, Jacob M ^ak   Hunzelmann, Nicolas ^al   Kreuter, Alexander ^am   Herrick, Ariane ^an   Worthington, Jane ^an   Radstake, Timothy R D J ^b   Martín, Javier ^a   Rueda, Blanca ^a,j   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF MILAN   (Italy)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^k HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^l HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^m HOSPITAL DE SABADELL   (Spain)

ⁿ Hospital del Doctor Peset Aleixandre   (Spain)

^o HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^p HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^q HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^r HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^s HOSPITAL DE CRUCES   (Spain)

^t HOSPITAL RAMÓN Y CAJAL   (Spain)

^u HOSPITAL DEL MAR   (Spain)

^v HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^w LUND UNIVERSITY HOSPITAL   (Sweden)

^x CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^y HANNOVER MEDICAL SCHOOL   (Germany)

^z UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^aa UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^ab GHENT UNIVERSITY   (Belgium)

^ac UNIVERSITY OF LEUVEN   (Belgium)

^ad VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ae LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^af UNIVERSITY OF GLASGOW   (United Kingdom)

^ag ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^ah KAROLINSKA INSTITUTE   (Sweden)

^ai OSLO UNIVERSITY HOSPITAL   (Norway)

^aj SPEDALI CIVILI   (Italy)

^ak NEWCASTLE UNIVERSITY   (United Kingdom)

^al UNIVERSITY OF COLOGNE   (Germany)

^am RUHR UNIVERSITY BOCHUM   (Germany)

^an UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; OX40 LIGAND;

ALLELE; ANTIBODY BLOOD LEVEL; ARTICLE; BELGIUM; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NETHERLANDS; NORWAY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; SYSTEMIC SCLEROSIS; UNITED KINGDOM;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; OX40 LIGAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SCLERODERMA, SYSTEMIC;

EID: 79952359835     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.141838     Document Type: Article

References (16)

1. Steen VD. The many faces of scleroderma. Rheum Dis Clin North Am 2008; 34 :1-15; v.
2. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008;34:17-40;v.
3. Agarwal SK, Reveille JD. The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 2010;22:133-8.
4. Zhou X, Lee JE, Arnett FC, et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum 2009;60:3807-14.
5. Radstake TR, Gorlova O, Rueda B, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010;42:426-9.
6. Gourh P, Arnett FC, Tan FK, et al. Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis 2010;69:550-5.
7. Manku H, Graham DS, Vyse TJ. Association of the co-stimulator OX40L with systemic lupus erythematosus. J Mol Med 2009;87:229-34.
8. Gough MJ, Weinberg AD. OX40 (CD134) and OX40L. Adv Exp Med Biol 2009;647:94-107.
9. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23 :581-90.
10. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
11. Skol AD, Scott LJ, Abecasis GR, et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-13. (Pubitemid 43177235)
12. Cunninghame Graham DS, Graham RR, Manku H, et al. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 2008;40:83-9.
13. Delgado-Vega AM, Abelson AK, Sánchez E, et al. Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus. Genes Immun 2009;10:248-53.
14. Croft M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 2010;28:57-78.
15. Croft M, So T, Duan W, et al. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 2009;229:173-91.
16. Radstake TR, van Bon L, Broen J, et al. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS ONE 2009;4:e5981.